Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NUWE

Nuwellis Inc

3.30

Jun 26 • 04:00PM ET -0.01 (-0.33%)

Healthcare Medical Devices USA Nano NASD

Jun 26, 5:30 PMReverse split creates low-float NUWE; pediatric PR sparks after-hours momentum surge

Peers: VTAK NVNO HSCS ICCM TNON MYO LFWD IRIX XAIR AEMD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-938.06	Insider Own	47.10%	Shs Outstand	0.51M	Perf Week	-29.37%
Market Cap	1.68M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.51M	Perf Month	-87.56%
Enterprise Value	-0.11M	PEG	-	EPS next Q	-	Inst Own	52.90%	Short Float	0.86%	Perf Quarter	-91.43%
Income	-19.00M	P/S	0.19	EPS this Y	92.50%	Inst Trans	-	Short Ratio	0.09	Perf Half Y	-95.40%
Sales	8.80M	P/B	3.27	EPS next Y	-	ROA	-272.80%	Short Interest	0.00M	Perf YTD	-94.58%
Book/sh	1.01	P/C	0.80	EPS next 5Y	-	ROE	-610.60%	52W High	908.25 -99.64%	Perf Year	-99.13%
Cash/sh	4.12	P/FCF	-	EPS past 3/5Y	94.09% -	ROIC	-376.40%	52W Low	2.88 14.56%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-1.08% 2.30%	Gross Margin	65.50%	Volatility	13.87% 17.05%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-0.01	EPS Y/Y TTM	91.63%	Oper. Margin	-	ATR (14)	1.92	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	1.00	Sales Y/Y TTM	-0.20%	Profit Margin	-	RSI (14)	14.11	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	1.60	EPS Q/Q	92.40%	SMA20	-61.92%	Beta	0.40	Target Price	-
Payout	0.00%	Debt/Eq	0.11	Sales Q/Q	26.30%	SMA50	-87.21%	Rel Volume	5.45	Prev Close	3.31
Employees	38	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-95.26%	Avg Volume	50.26K	Price	3.30
IPO	Feb 16, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	-109.00% 14.76%	Trades		Volume	273,896	Change	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-24	Initiated	ROTH MKM	Buy	$17

Jun-26-26 08:00AM	Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC4) (GlobeNewswire)
Jun-25-26 08:30AM	Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow Installations (GlobeNewswire) +6.29%
Jun-24-26 08:30AM	Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders (GlobeNewswire) -30.47%
Jun-18-26 08:30AM	Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit (GlobeNewswire)
Jun-16-26 08:30AM	Nuwellis Appoints Mike McCormick as Chief Executive Officer (GlobeNewswire)
08:30AM	Loading…
Jun-10-26 08:30AM	Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow Devices at One of its Children's Hospitals (GlobeNewswire)
Jun-08-26 09:46PM	Nuwellis Announces Closing of $6.0 Million Registered Public Offering (GlobeNewswire) -13.28%
Jun-05-26 10:29AM	Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE) (InvestorsHub) -61.21%
08:30AM	Nuwellis Announces Pricing of $6 Million Public Offering (GlobeNewswire)
May-14-26 08:30AM	Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label (GlobeNewswire)
May-12-26 07:01PM	Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
01:19PM	Nuwellis, Inc. Q1 2026 Earnings Call Summary (Moby)
08:00AM	Nuwellis, Inc. Announces First Quarter 2026 Financial Results (GlobeNewswire)
May-05-26 08:00AM	Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026 (GlobeNewswire)
Apr-29-26 08:30AM	Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting (GlobeNewswire)
08:30AM	Loading…
Apr-28-26 08:30AM	Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology (GlobeNewswire)
Apr-23-26 08:30AM	Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat (GlobeNewswire)
Apr-21-26 08:30AM	Nuwellis Announces Aquadex Software Update (GlobeNewswire)
Apr-16-26 08:30AM	Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum (GlobeNewswire)
Apr-09-26 08:30AM	Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services (GlobeNewswire)
Apr-07-26 08:30AM	Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory (GlobeNewswire)
Mar-31-26 08:30AM	Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone (GlobeNewswire)
Mar-17-26 08:00AM	Nuwellis Completes Acquisition of Rendiatech (GlobeNewswire) -8.47%
Mar-10-26 12:43PM	Nuwellis, Inc. Q4 2025 Earnings Call Summary (Moby)
08:15AM	Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-05-26 08:00AM	Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy (GlobeNewswire) -5.13%
Feb-26-26 08:00AM	Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors (GlobeNewswire)
Feb-24-26 08:00AM	Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 (GlobeNewswire)
Jan-30-26 08:00AM	Nuwellis Appoints Carisa Schultz as Chief Financial Officer (GlobeNewswire) -10.02%
Jan-29-26 04:36PM	Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market (GlobeNewswire) +8.55%
04:35PM	Loading…
04:35PM	Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy (GlobeNewswire)
Jan-27-26 11:14AM	Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare (Benzinga) +78.14%
Jan-23-26 04:40PM	Nuwellis Announces Changes to Board of Directors (GlobeNewswire)
Jan-06-26 08:15AM	Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy (GlobeNewswire)
Dec-09-25 08:15AM	Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings (GlobeNewswire)
Dec-04-25 08:15AM	Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. (GlobeNewswire) +12.39%
Nov-12-25 04:03PM	Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... (GuruFocus.com) -8.43%
08:15AM	Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum (GlobeNewswire)
Nov-10-25 09:00AM	Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian Pediatric System with Advanced Clamp Safety Technology (GlobeNewswire) -5.57%
Oct-23-25 09:00AM	Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 (GlobeNewswire)
Sep-30-25 08:45AM	Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex (GlobeNewswire) -5.10%
Sep-18-25 09:00AM	Nuwellis Receives New US Patent Reinforcing Vivian Pediatric Device Focused on Safer, More Precise Ultrafiltration (GlobeNewswire)
Sep-17-25 10:16AM	Nuwellis, Inc. Participates in a Virtual Investor "What This Means" Segment (GlobeNewswire)
Sep-09-25 09:00AM	Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio (GlobeNewswire) -9.01%
Sep-04-25 08:15AM	Nuwellis Introduces New 24-Hour Aquadex Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management (GlobeNewswire)
Aug-21-25 08:15AM	Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter (GlobeNewswire)
Aug-19-25 08:15AM	Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company (GlobeNewswire) -5.40%
Aug-15-25 08:15AM	Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech (GlobeNewswire)
03:17AM	Nuwellis Inc (NUWE) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Challenges (GuruFocus.com)
Aug-14-25 08:15AM	Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
Aug-07-25 08:15AM	Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus (GlobeNewswire)
Aug-06-25 08:15AM	Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025 (GlobeNewswire)
Aug-05-25 08:15AM	Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow System Under New CMS Code (GlobeNewswire) -21.18%
Aug-04-25 05:24PM	Nuwellis Stockholders Approve All Proposals at Special Meeting (GlobeNewswire) -27.36%
Jul-23-25 08:45AM	Nuwellis Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference (GlobeNewswire)
08:15AM	Nuwellis Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Jul-22-25 08:40AM	JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live (ACCESSWIRE)
08:15AM	Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Jul-17-25 07:35AM	Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care (GlobeNewswire)
Jul-16-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +131.33%
Jul-15-25 04:05PM	Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation (GlobeNewswire) -11.72%
Jul-02-25 08:15AM	Nuwellis Appoints John Erb as Chief Executive Officer (GlobeNewswire) -5.10%
Jun-10-25 04:15PM	Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option (GlobeNewswire) +57.56%
09:20AM	Nuwellis announces pricing of $4.3M underwritten public offering (TipRanks)
Jun-09-25 09:15AM	Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering (GlobeNewswire) -42.94%
May-14-25 03:10AM	Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges (GuruFocus.com)
May-13-25 08:15AM	Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
May-12-25 07:00AM	Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency (GlobeNewswire)
May-08-25 06:35PM	CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Nuwellis Expands Aquadex for Pediatric Fluid Management to Two New Hospital Systems (GlobeNewswire)
Apr-30-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-24-25 07:00AM	Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision (GlobeNewswire) +7.24%
Apr-22-25 04:05PM	Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-21-25 05:02PM	Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com)
Mar-11-25 08:00AM	Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-24-25 04:05PM	Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO (GlobeNewswire) -5.56%
Feb-20-25 08:00AM	JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis (GlobeNewswire) -6.85%
Feb-18-25 04:15PM	Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 (GlobeNewswire) +11.45%
Jan-13-25 08:00AM	Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow Therapy (GlobeNewswire)
Dec-19-24 09:00AM	Nuwellis Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Nov-11-24 08:00AM	Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights (GlobeNewswire) +13.26%
Nov-05-24 09:28AM	Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds (GlobeNewswire) -34.52%
Nov-04-24 01:43PM	Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System (GuruFocus.com) +106.62%
08:30AM	Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow Therapy from the Centers for Medicare and Medicaid (GlobeNewswire)
Nov-01-24 04:15PM	Nuwellis Announces Preliminary Results for Third Quarter of 2024 (GlobeNewswire) -20.93%
Oct-31-24 08:00AM	Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer (GlobeNewswire) -11.79%
Oct-23-24 04:15PM	Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire) -26.27% -5.75%
Sep-25-24 04:15PM	Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference (GlobeNewswire)
Aug-27-24 09:00AM	New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy (GlobeNewswire)
Aug-23-24 09:00AM	Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -26.16%
Aug-13-24 08:00AM	Nuwellis, Inc. Announces Second Quarter 2024 Financial Results (GlobeNewswire) -19.25%
Aug-08-24 09:00AM	Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions (GlobeNewswire)
Jul-26-24 09:00AM	Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE Therapy at Cincinnati Children's (GlobeNewswire)
Jul-24-24 08:02AM	Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -40.00%
Jul-23-24 04:10PM	Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024 (GlobeNewswire) +8.36%
Jul-17-24 09:00AM	Nuwellis Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children's (GlobeNewswire) -6.77%
Jul-12-24 08:30AM	SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner (GlobeNewswire) +8.70%
07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-09-24 09:00AM	New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference (GlobeNewswire)

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

CEOMr. John L. Erb

Senior VPMr. Neil P. Ayotte Esq.

CFOMs. Carisa Schultz

Vice President of OperationsMs. Kim Anderson

Chief Technology OfficerMr. David Lerner

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NUWE

Nuwellis Inc

Upgrade your Finviz experience